In spite of recent advances in secondary prevention, sudden cardiac death h
as remained a major public health problem as the majority of fatalities occ
ur in subjects without a history of severe heart disease. Abrupt rapture of
a vulnerable plaque resulting in thrombotic occlusion of a coronary artery
is a common cause of sudden death in this population. Coronary occlusion d
oes not, however, invariably lead to sudden death bur may cause acute myoca
rdial infarction or exacerbation of chest pain. Extensive studies in experi
mental animals and increasing clinical evidence indicate that autonomic ner
vous activity has a significant role in modifying the clinical outcome. Sym
pathetic hyperactivity favours the genesis of life-threatening ventricular
tachyarrhythmias while vagal activation exerts an antifibrillatory effect.
Strong afferent stimuli from the ischaemic myocardium impair arterial baror
eflex and may lead to dangerous haemodynamic instability. Studies with a hu
man angioplasty model have shown that there is wide interindividual variati
on in the type and severity of autonomic reactions during the early phase o
f abrupt coronary occlusion, a critical period for out-of-hospital cardiac
arrest. The site of the occlusion is not a significant determinant of the r
eactions, whereas the severity of a coronary stenosis, adaptation or ischae
mic preconditioning, beta-blockade and gender seem to affect the autonomic
reactions and occurrence of complex ventricular arrhythmias. Clinical and a
ngiographic factors are, however, poor predictors of autonomic reactions in
an individual patient, Recent studies have documented a hereditary compone
nt for autonomic function, and genetic factors may also modify the clinical
manifestations of acute coronary occlusion.